Market Cap 370.71M
Revenue (ttm) 40,000.00
Net Income (ttm) -56.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -140,600.01%
Debt to Equity Ratio 0.00
Volume 8,666,800
Avg Vol 1,808,080
Day's Range N/A - N/A
Shares Out 87.02M
Stochastic %K 85%
Beta 1.18
Analysts Sell
Price Target $4.45

Company Profile

Checkpoint Therapeutics, Inc., a commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is UNLOXCYT, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignanci...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 652 4500
Fax: 646 619 4950
Address:
95 Sawyer Road, Suite 110, Waltham, United States
sujeto
sujeto Sep. 23 at 2:31 PM
$CKPT dead stock
0 · Reply
Renato17
Renato17 Aug. 28 at 12:53 PM
0 · Reply
TREBLALBERT
TREBLALBERT Aug. 25 at 4:16 PM
0 · Reply
SophieAllan6
SophieAllan6 Aug. 25 at 3:10 PM
$CKPT Let's keep an eye on that price target together!
0 · Reply
blackwlf
blackwlf Aug. 22 at 4:50 PM
$HUBC is at least 10x undervalued when compared to peers $CYBR $CKPT. It's cyber security and shorts keep forgetting it.
0 · Reply
jjangles123
jjangles123 Aug. 7 at 6:30 PM
$MIST Another pattern, $CKPT had CRL, steep drop, announced offering, a drop. Then the run up that resulted in PDUFA acceptance Dec 2024 doubled. Which is exactly where we are right now.
0 · Reply
TwongStocks
TwongStocks Jul. 30 at 1:05 PM
$CKPT For everyone asking about updates. The best place to get updates is from Sun Pharma. Unfortunately, they aren't traded in the US, so no SEC filings. But you can view their press releases here: https://sunpharma.com/media/ The big thing to pay attention to is when they announce positive validation of the MAA for UNLOXCYT. That starts the clock. To get the $0.70 payout, UNLOXCYT needs to be approved within 2 years of positive MAA validation at an approved dose of once very 3 weeks (see chart). Per the agreement, Sun has to submit UNLOXCYT's MAA in Europe by May 30, 2026. After it is submitted, they have to wait for it to be validated before the EMA starts the approval process.
0 · Reply
Latest News on CKPT
Sun Pharma to Acquire Checkpoint Therapeutics

Mar 9, 2025, 10:06 PM EDT - 8 months ago

Sun Pharma to Acquire Checkpoint Therapeutics

FBIO


sujeto
sujeto Sep. 23 at 2:31 PM
$CKPT dead stock
0 · Reply
Renato17
Renato17 Aug. 28 at 12:53 PM
0 · Reply
TREBLALBERT
TREBLALBERT Aug. 25 at 4:16 PM
0 · Reply
SophieAllan6
SophieAllan6 Aug. 25 at 3:10 PM
$CKPT Let's keep an eye on that price target together!
0 · Reply
blackwlf
blackwlf Aug. 22 at 4:50 PM
$HUBC is at least 10x undervalued when compared to peers $CYBR $CKPT. It's cyber security and shorts keep forgetting it.
0 · Reply
jjangles123
jjangles123 Aug. 7 at 6:30 PM
$MIST Another pattern, $CKPT had CRL, steep drop, announced offering, a drop. Then the run up that resulted in PDUFA acceptance Dec 2024 doubled. Which is exactly where we are right now.
0 · Reply
TwongStocks
TwongStocks Jul. 30 at 1:05 PM
$CKPT For everyone asking about updates. The best place to get updates is from Sun Pharma. Unfortunately, they aren't traded in the US, so no SEC filings. But you can view their press releases here: https://sunpharma.com/media/ The big thing to pay attention to is when they announce positive validation of the MAA for UNLOXCYT. That starts the clock. To get the $0.70 payout, UNLOXCYT needs to be approved within 2 years of positive MAA validation at an approved dose of once very 3 weeks (see chart). Per the agreement, Sun has to submit UNLOXCYT's MAA in Europe by May 30, 2026. After it is submitted, they have to wait for it to be validated before the EMA starts the approval process.
0 · Reply